Unlock the Potential of 3D

The advent of 3D mammography has delivered game-changing promise and potential to the world of healthcare. By any of its many labels – digital breast tomosynthesis, DBT, tomosynthesis, or simply tomo – this modality offers patients as well as service providers a win-win that cannot be ignored.

Some sobering statistics

  • In the United States, one in eight women, or about 12%, will develop invasive breast cancer over the course of her lifetime. [BREASTCANCER.ORG]
  • Breast cancer death rates remain second only to lung cancer for U.S. women. [BREASTCANCER.ORG]
  • The number of new cases and deaths is increasing each year, due to a growing and aging population. [CDC.GOV]
  • There were over 2 million new cases of breast cancer diagnosed worldwide in 2018. [KOMEN.ORG]
  • Approximately 30% of newly diagnosed cancers in American women in 2019 will be breast cancers. [BREASTCANCER.ORG]

The Best Defense

Regular screening for and early detection of breast cancer is indisputably the best defense against this pervasive disease. And of course, patients want the best and most effective screening and diagnostic technology available to them.

Research studies continue to affirm the advantages of DBT over 2D mammography in better detection – especially for the most lethal cancers – and reduced call backs. Insurance coverage for DBT is becoming widespread, especially in the U.S., aided by state-level mandates in many cases. Medicare began covering DBT in 2015.

In the early days, the upfront investment required to offer DBT interpretations was prohibitive for many imaging operations. The cost of acquiring and maintaining specialized workstations, plus the productivity hit of introducing a tangential workflow and new skillset to the users of those costly workstations, was a significant barrier to entry.

Today, this barrier has been eliminated because the availability of all-in-one integrated breast imaging workflow solutions removes the need to invest in specialized hardware and software. What used to require a separate workflow and a separate, high-end workstation – perhaps in another room or even at another facility – can now be accomplished from the same fully-featured diagnostic viewer on all the same machines used for other interpretations and modalities.


An Upward Trend

More facilities are embracing DBT technology. Statistics collected by the FDA, which certifies imaging facilities across the U.S. through the Mammography Quality Standards Act, show a nearly 60% increase in certified mammography facilities offering DBT between March 2017 and March 2019 (from 3,178 to 5,047). [FDA.GOV]


Source: FDA.gov > Radiation-Emiting Products > Mammography Quality Standards Acts and Program > MQSA National Statistics


Developed in collaboration with DBT pioneers, Intelerad’s all-in-one integrated breast imaging solution extends its industry-leading PACS, offering a multi-modality worklist, user configurable layout protocols, high-performance image streaming, and optimized workflow designed especially for digital mammography – all of which combine to maximize radiologist efficiency and effectiveness.

As patients, and especially women, become more discriminating consumers of healthcare services, they seek the best that technology can deliver. Introduce or expand your DBT interpretation services with a high-performance, all-in-one solution to unlock the potential of 3D mammography.